Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected
Jaskłowska-Englisz, M.; Olszewski, W.L.
Transplantation Proceedings 26(6): 3463
1994
ISSN/ISBN: 0041-1345 PMID: 7998224 Document Number: 431805
Document emailed within 1 workday
Related Documents
Schulak, J.A.; Cooke, J.C.; Herrmann, M.J. 1990: Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts Transplantation 50(2): 341-343Goss, J.A.; Nakafusa, Y.; Yu, S.; Flye, M.W. 1993: Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection Transplantation Proceedings 25(1 Part 1): 286-288
Lee, T.K.; Langrehr, J.M.; Moynihan, H.L.; Stangl, M.J.; Lee, K.K.; Schraut, W.H. 1992: Failure of donor irradiation to prolong allograft survival in small bowel transplantation in rats Transplantation Proceedings 24(3): 1183-1184
Romaniuk, A.; Ryffa, T.; Rowiński, W.; Olszewski, W.L. 1989: Prolongation of heart allograft survival in course of donor specific antigen and alloserum treatment in the rat Archivum Immunologiae et Therapiae Experimentalis 37(3-4): 253-260
Kamei, T.; Callery, M.P.; Flye, M.W. 1990: Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival Surgery 108(2): 415
Christiaans, M.H.; van Hooff, J.P.; Nieman, F.; van den Berg-Loonen, E.M. 1999: HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome Transplantation 67(7): 1029-1035
Bordes-Aznar, J.; Odor, A.; Dib-Kuri, A.; Gabilondo, F.; Kasep, J.; Peña, J.C.; Herrera-Acosta, J.; Chávez-Peón, F. 1987: Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation Transplantation Proceedings 19(1 Pt 3): 2276-2277
Sintnicolaas, K.; Vriesendorp, H.M.; Sizoo, W.; Stenfert Kroese, W.F.; Haije, W.G.; Hop, W.C.; Abels, J.; Löwenberg, B. 1981: Delayed alloimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia Lancet 1(8223): 750-754
Matsumoto, T.; Sakagami, K.; Orita, K. 1987: Role of donor specific blood transfusions in prolongation of kidney graft survival Transplantation Proceedings 19(1 Part 3): 2264-2267
Davies, C.B.; Cofer, B.R.; Alexander, J.W. 1991: Effects of donor-specific transfusion, cyclosporine a and FK 506 on rat cardiac allograft survival Transplantation Proceedings 23(6): 3314-3315
Choti, M.; Lenrow, D.; Roza, A.; Markmann, J.; Naji, A. 1989: Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells Transplantation Proceedings 21(1 Pt 1): 478-479
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Nakajima, N.; Sakai, A.; Kountz, S.L. 1976: Effect of host pretreatment with immunosuppression and donor antigen on heart allograft survival in rats Surgical Forum 27(62): 338-339
Ketchum, R.J.; Moore, W.V.; Hegre, O.D. 1992: Increased islet allograft survival after extended culture by a mechanism other than depletion of donor APCs. Lack of correlation between the elimination of donor MHC class II-positive accessory cells and increased transplantability Transplantation 54(2): 347-351
Ringers, J.; Haanstra, K.G.; Kroczek, R.A.; Kliem, K.; Kuhn, E.M.; Wubben, J.; Ossevoort, M.A.; Volk, H.Dieter.; Jonker, M. 2002: Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates Transplantation 73(6): 862-866
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Bartlett, S.T.; Ward, R.E. 1989: Donor specific transfusions in rodent pancreatic transplantation Transplantation Proceedings 21(1 Part 1): 1185-1186
Tyler, J.D.; Anderson, C.B.; Sicard, G.A. 1987: Interleukin 2 response inhibition following donor specific transfusions given with azathioprine Transplantation Proceedings 19(1 Part 3): 2258-2261
Goto, M.; Yamaguchi, Y.; Matsuno, K.; Takata, N.; Makino, Y.; Kikuchi, N.; Hamaguchi, H.; Hisama, N.; Otsuka, Y.; Mori, K. 1993: Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: the distribution of donor class I-positive cells in the recipient Transplantation Proceedings 25(2): 1893-1895
Shapira, Z.; Yussim, A.; Shmueli, D.; Mahinson, A.; Reichenthal, E.; Servadio, C. 1987: Renal retransplantation from living related donors using donor specific blood transfusions Transplantation Proceedings 19(1 Part 3): 2280-2281